Biotechnology Company Presents Near-Term Value Catalysts For IBD Treatment
Organovo Highlights FXR314 Near-Term Value Catalysts at Jones Trading Conference.
Disclaimer: The information provided in this article is for informational purposes only and should not be construed as investment advice. The views expressed in this article are based on publicly available information about Organovo Holdings, Inc. and do not constitute an endorsement or recommendation of any particular securities…